Trastuzumab Deruxtecan Demonstrates Real-World Intracranial

Data from a real-world study in Japan showed that fam-trastuzumab deruxtecan-nxki displayed intracranial efficacy in patients with HER2-positive breast cancer harboring brain metastases and/or leptomeningeal carcinomatosis.

Related Keywords

Japan , Kanagawa , Fukushima , Naoki Niikura , , Breast Oncology , Tokai University School , Trastuzumab Deruxtecan , Phase 3 Destiny Breast04 Trial , Japans Ministry Of Health , Labor And Welfare , Min000044995 , Brain Metastases And Or Leptomeningeal Carcinomatosis , Her2 Positive Breast Cancer ,